Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for ARNT
Z-value: 0.22
Motif logo
Transcription factors associated with ARNT
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ARNT
|
ENSG00000143437.16 | aryl hydrocarbon receptor nuclear translocator |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ARNT | hg19_v2_chr1_-_150849208_150849244 | 0.26 | 1.5e-01 | Click! |
Activity profile of ARNT motif
Sorted Z-values of ARNT motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_+_100211412 | 3.31 |
ENST00000323523.4
ENST00000403410.1 ENST00000449609.1 |
TMEM45A
|
transmembrane protein 45A |
| chr11_+_76494253 | 3.31 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
| chr7_+_94023873 | 2.75 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chr7_-_27170352 | 2.62 |
ENST00000428284.2
ENST00000360046.5 |
HOXA4
|
homeobox A4 |
| chr6_+_31865552 | 2.41 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
| chr11_-_64014379 | 2.19 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr5_-_172755056 | 1.97 |
ENST00000520648.1
|
STC2
|
stanniocalcin 2 |
| chr1_+_209848749 | 1.90 |
ENST00000367029.4
|
G0S2
|
G0/G1switch 2 |
| chr2_-_28113965 | 1.71 |
ENST00000302188.3
|
RBKS
|
ribokinase |
| chr6_+_43739697 | 1.66 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr3_+_5020801 | 1.66 |
ENST00000256495.3
|
BHLHE40
|
basic helix-loop-helix family, member e40 |
| chrX_+_105969893 | 1.65 |
ENST00000255499.2
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr7_-_139876812 | 1.40 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr17_+_72428218 | 1.35 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr3_-_50329835 | 1.34 |
ENST00000429673.2
|
IFRD2
|
interferon-related developmental regulator 2 |
| chr19_-_55895966 | 1.31 |
ENST00000444469.3
|
TMEM238
|
transmembrane protein 238 |
| chr2_+_10183651 | 1.31 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr8_+_17354617 | 1.29 |
ENST00000470360.1
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
| chrX_+_23685563 | 1.29 |
ENST00000379341.4
|
PRDX4
|
peroxiredoxin 4 |
| chr7_-_100425112 | 1.28 |
ENST00000358173.3
|
EPHB4
|
EPH receptor B4 |
| chr8_+_30241995 | 1.26 |
ENST00000397323.4
ENST00000339877.4 ENST00000320203.4 ENST00000287771.5 |
RBPMS
|
RNA binding protein with multiple splicing |
| chr11_-_76381781 | 1.26 |
ENST00000260061.5
ENST00000404995.1 |
LRRC32
|
leucine rich repeat containing 32 |
| chr6_-_39197226 | 1.25 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
| chr8_+_17354587 | 1.25 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
| chr12_+_54519842 | 1.25 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
| chr3_+_122785895 | 1.23 |
ENST00000316218.7
|
PDIA5
|
protein disulfide isomerase family A, member 5 |
| chr2_+_201171372 | 1.21 |
ENST00000409140.3
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
| chr9_-_112083229 | 1.21 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
| chr6_+_89791507 | 1.19 |
ENST00000354922.3
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
| chr3_-_71834318 | 1.19 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
| chr12_+_3069037 | 1.18 |
ENST00000397122.2
|
TEAD4
|
TEA domain family member 4 |
| chr1_+_6484829 | 1.17 |
ENST00000377828.1
|
ESPN
|
espin |
| chr6_+_64282447 | 1.12 |
ENST00000370650.2
ENST00000578299.1 |
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
| chr2_+_111878483 | 1.12 |
ENST00000308659.8
ENST00000357757.2 ENST00000393253.2 ENST00000337565.5 ENST00000393256.3 |
BCL2L11
|
BCL2-like 11 (apoptosis facilitator) |
| chrX_+_23685653 | 1.11 |
ENST00000379331.3
|
PRDX4
|
peroxiredoxin 4 |
| chr17_+_72428266 | 1.11 |
ENST00000582473.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr11_+_57435219 | 1.10 |
ENST00000527985.1
ENST00000287169.3 |
ZDHHC5
|
zinc finger, DHHC-type containing 5 |
| chr7_+_100318423 | 1.09 |
ENST00000252723.2
|
EPO
|
erythropoietin |
| chr13_+_73632897 | 1.09 |
ENST00000377687.4
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
| chr15_+_45722727 | 1.09 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
| chr11_+_18416133 | 1.07 |
ENST00000227157.4
ENST00000478970.2 ENST00000495052.1 |
LDHA
|
lactate dehydrogenase A |
| chr15_-_65503801 | 1.07 |
ENST00000261883.4
|
CILP
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
| chr8_+_30241934 | 1.07 |
ENST00000538486.1
|
RBPMS
|
RNA binding protein with multiple splicing |
| chr4_-_39529049 | 1.05 |
ENST00000501493.2
ENST00000509391.1 ENST00000507089.1 |
UGDH
|
UDP-glucose 6-dehydrogenase |
| chr2_+_201170999 | 1.04 |
ENST00000439395.1
ENST00000444012.1 |
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
| chr2_+_176972000 | 1.04 |
ENST00000249504.5
|
HOXD11
|
homeobox D11 |
| chr1_-_92351666 | 1.03 |
ENST00000465892.2
ENST00000417833.2 |
TGFBR3
|
transforming growth factor, beta receptor III |
| chr10_-_93392811 | 1.03 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
| chr3_+_186648507 | 1.02 |
ENST00000458216.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
| chr4_-_39529180 | 1.02 |
ENST00000515021.1
ENST00000510490.1 ENST00000316423.6 |
UGDH
|
UDP-glucose 6-dehydrogenase |
| chr16_-_68269971 | 1.01 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr12_+_3068957 | 1.01 |
ENST00000543035.1
|
TEAD4
|
TEA domain family member 4 |
| chr17_-_8059638 | 1.00 |
ENST00000584202.1
ENST00000354903.5 ENST00000577253.1 |
PER1
|
period circadian clock 1 |
| chr1_-_92351769 | 0.99 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
| chr4_+_76649753 | 0.98 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
| chr11_+_18416103 | 0.98 |
ENST00000543445.1
ENST00000430553.2 ENST00000396222.2 ENST00000535451.1 |
LDHA
|
lactate dehydrogenase A |
| chr5_-_172198190 | 0.95 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
| chr1_-_19229014 | 0.95 |
ENST00000538839.1
ENST00000290597.5 |
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
| chr11_-_118901559 | 0.94 |
ENST00000330775.7
ENST00000545985.1 ENST00000357590.5 ENST00000538950.1 |
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
| chr15_+_96875657 | 0.94 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr5_-_131563474 | 0.94 |
ENST00000417528.1
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
| chr6_+_44191290 | 0.93 |
ENST00000371755.3
ENST00000371740.5 ENST00000371731.1 ENST00000393841.1 |
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
| chr1_+_43637996 | 0.93 |
ENST00000528956.1
ENST00000529956.1 |
WDR65
|
WD repeat domain 65 |
| chr2_-_157189180 | 0.92 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
| chr3_-_50329990 | 0.92 |
ENST00000417626.2
|
IFRD2
|
interferon-related developmental regulator 2 |
| chr6_+_44191507 | 0.92 |
ENST00000371724.1
ENST00000371713.1 |
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
| chr17_-_882966 | 0.92 |
ENST00000336868.3
|
NXN
|
nucleoredoxin |
| chr16_+_3070356 | 0.92 |
ENST00000341627.5
ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
| chr7_-_139876734 | 0.91 |
ENST00000006967.5
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr7_+_65540853 | 0.90 |
ENST00000380839.4
ENST00000395332.3 ENST00000362000.5 ENST00000395331.3 |
ASL
|
argininosuccinate lyase |
| chr12_+_56862301 | 0.89 |
ENST00000338146.5
|
SPRYD4
|
SPRY domain containing 4 |
| chr2_+_201170770 | 0.89 |
ENST00000409988.3
ENST00000409385.1 |
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
| chr11_-_6341724 | 0.88 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
| chr6_+_7727030 | 0.88 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
| chr2_+_201171064 | 0.87 |
ENST00000451764.2
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
| chr3_-_145878954 | 0.86 |
ENST00000282903.5
ENST00000360060.3 |
PLOD2
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
| chr14_-_54423529 | 0.86 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr9_+_2622085 | 0.86 |
ENST00000382099.2
|
VLDLR
|
very low density lipoprotein receptor |
| chr20_-_44540686 | 0.86 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
| chr7_+_65540780 | 0.86 |
ENST00000304874.9
|
ASL
|
argininosuccinate lyase |
| chr1_-_6269448 | 0.85 |
ENST00000465335.1
|
RPL22
|
ribosomal protein L22 |
| chr1_-_19229248 | 0.84 |
ENST00000375341.3
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
| chr2_-_220083692 | 0.84 |
ENST00000265316.3
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
| chr11_+_57435441 | 0.83 |
ENST00000528177.1
|
ZDHHC5
|
zinc finger, DHHC-type containing 5 |
| chr3_-_185542761 | 0.82 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr5_+_38846101 | 0.82 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
| chr2_-_220083671 | 0.82 |
ENST00000439002.2
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
| chr16_+_3070313 | 0.82 |
ENST00000326577.4
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
| chr3_+_186649133 | 0.79 |
ENST00000417392.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
| chr5_-_131563501 | 0.79 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
| chr2_+_201171577 | 0.79 |
ENST00000409397.2
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
| chr2_-_220083076 | 0.79 |
ENST00000295750.4
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
| chr22_-_31741757 | 0.79 |
ENST00000215919.3
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
| chr6_+_123110465 | 0.79 |
ENST00000539041.1
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
| chr11_-_59436453 | 0.77 |
ENST00000300146.9
|
PATL1
|
protein associated with topoisomerase II homolog 1 (yeast) |
| chr3_-_185542817 | 0.76 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr20_-_10654639 | 0.76 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
| chrX_-_128977364 | 0.75 |
ENST00000371064.3
|
ZDHHC9
|
zinc finger, DHHC-type containing 9 |
| chr9_-_34637718 | 0.75 |
ENST00000378892.1
ENST00000277010.4 |
SIGMAR1
|
sigma non-opioid intracellular receptor 1 |
| chr1_+_44445549 | 0.75 |
ENST00000356836.6
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
| chr10_-_76995769 | 0.75 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr8_+_126442563 | 0.75 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
| chr10_+_120967072 | 0.74 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
| chr19_+_18530146 | 0.74 |
ENST00000348495.6
ENST00000270061.7 |
SSBP4
|
single stranded DNA binding protein 4 |
| chr14_+_63671577 | 0.74 |
ENST00000555125.1
|
RHOJ
|
ras homolog family member J |
| chr21_-_40032581 | 0.74 |
ENST00000398919.2
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
| chr6_+_64281906 | 0.74 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
| chr6_-_139695757 | 0.74 |
ENST00000367651.2
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
| chr16_+_447226 | 0.73 |
ENST00000433358.1
|
NME4
|
NME/NM23 nucleoside diphosphate kinase 4 |
| chr19_-_46272106 | 0.73 |
ENST00000560168.1
|
SIX5
|
SIX homeobox 5 |
| chr22_+_38864041 | 0.73 |
ENST00000216014.4
ENST00000409006.3 |
KDELR3
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
| chr7_+_116312411 | 0.73 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
| chr10_-_101945771 | 0.73 |
ENST00000370408.2
ENST00000407654.3 |
ERLIN1
|
ER lipid raft associated 1 |
| chr11_-_67276100 | 0.72 |
ENST00000301488.3
|
CDK2AP2
|
cyclin-dependent kinase 2 associated protein 2 |
| chr1_-_6259613 | 0.72 |
ENST00000465387.1
|
RPL22
|
ribosomal protein L22 |
| chr14_+_74004051 | 0.71 |
ENST00000557556.1
|
ACOT1
|
acyl-CoA thioesterase 1 |
| chr10_-_76995675 | 0.71 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr11_-_64889649 | 0.69 |
ENST00000434372.2
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed |
| chr1_-_59249732 | 0.69 |
ENST00000371222.2
|
JUN
|
jun proto-oncogene |
| chr10_+_101419187 | 0.69 |
ENST00000370489.4
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
| chr9_-_94186131 | 0.69 |
ENST00000297689.3
|
NFIL3
|
nuclear factor, interleukin 3 regulated |
| chr5_+_34656331 | 0.69 |
ENST00000265109.3
|
RAI14
|
retinoic acid induced 14 |
| chr7_-_6523688 | 0.68 |
ENST00000490996.1
|
KDELR2
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
| chr2_-_96781984 | 0.68 |
ENST00000409345.3
|
ADRA2B
|
adrenoceptor alpha 2B |
| chr15_+_41056255 | 0.68 |
ENST00000561160.1
ENST00000559445.1 |
GCHFR
|
GTP cyclohydrolase I feedback regulator |
| chr5_+_38845960 | 0.67 |
ENST00000502536.1
|
OSMR
|
oncostatin M receptor |
| chr3_+_32433363 | 0.67 |
ENST00000465248.1
|
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7 |
| chr20_-_590944 | 0.67 |
ENST00000246080.3
|
TCF15
|
transcription factor 15 (basic helix-loop-helix) |
| chr2_+_27665289 | 0.67 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
| chr11_+_69455855 | 0.67 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
| chr11_-_118972575 | 0.67 |
ENST00000432443.2
|
DPAGT1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
| chr1_+_44445643 | 0.66 |
ENST00000309519.7
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
| chr16_-_54963026 | 0.66 |
ENST00000560208.1
ENST00000557792.1 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
| chr20_+_3052264 | 0.66 |
ENST00000217386.2
|
OXT
|
oxytocin/neurophysin I prepropeptide |
| chr9_-_110251836 | 0.66 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
| chr1_+_26496362 | 0.65 |
ENST00000374266.5
ENST00000270812.5 |
ZNF593
|
zinc finger protein 593 |
| chr15_+_41056218 | 0.65 |
ENST00000260447.4
|
GCHFR
|
GTP cyclohydrolase I feedback regulator |
| chr2_-_10587897 | 0.65 |
ENST00000405333.1
ENST00000443218.1 |
ODC1
|
ornithine decarboxylase 1 |
| chr1_+_230202936 | 0.65 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr2_+_192543153 | 0.65 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
| chr1_+_45140400 | 0.64 |
ENST00000453711.1
|
C1orf228
|
chromosome 1 open reading frame 228 |
| chr11_+_72929319 | 0.64 |
ENST00000393597.2
ENST00000311131.2 |
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
| chr3_-_73673991 | 0.64 |
ENST00000308537.4
ENST00000263666.4 |
PDZRN3
|
PDZ domain containing ring finger 3 |
| chr19_+_6739662 | 0.64 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chr1_+_230203010 | 0.64 |
ENST00000541865.1
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr9_+_133884469 | 0.63 |
ENST00000361069.4
|
LAMC3
|
laminin, gamma 3 |
| chr4_-_103266626 | 0.63 |
ENST00000356736.4
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
| chr7_-_72971934 | 0.63 |
ENST00000411832.1
|
BCL7B
|
B-cell CLL/lymphoma 7B |
| chr17_+_79679369 | 0.62 |
ENST00000350690.5
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
| chrX_-_128977781 | 0.62 |
ENST00000357166.6
|
ZDHHC9
|
zinc finger, DHHC-type containing 9 |
| chr1_-_154193009 | 0.62 |
ENST00000368518.1
ENST00000368519.1 ENST00000368521.5 |
C1orf43
|
chromosome 1 open reading frame 43 |
| chr12_-_15374343 | 0.62 |
ENST00000256953.2
ENST00000546331.1 |
RERG
|
RAS-like, estrogen-regulated, growth inhibitor |
| chr18_+_6729698 | 0.62 |
ENST00000383472.4
|
ARHGAP28
|
Rho GTPase activating protein 28 |
| chr17_+_79679299 | 0.62 |
ENST00000331531.5
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
| chr1_-_19229218 | 0.61 |
ENST00000432718.1
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
| chr11_+_72929402 | 0.61 |
ENST00000393596.2
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
| chr3_+_47021168 | 0.61 |
ENST00000450053.3
ENST00000292309.5 ENST00000383740.2 |
NBEAL2
|
neurobeachin-like 2 |
| chr3_-_128840604 | 0.61 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
| chr1_-_154193091 | 0.61 |
ENST00000362076.4
ENST00000350592.3 ENST00000368516.1 |
C1orf43
|
chromosome 1 open reading frame 43 |
| chr11_-_65641044 | 0.61 |
ENST00000527378.1
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
| chr9_-_73029540 | 0.61 |
ENST00000377126.2
|
KLF9
|
Kruppel-like factor 9 |
| chr11_-_66336060 | 0.61 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
| chr5_+_34656569 | 0.60 |
ENST00000428746.2
|
RAI14
|
retinoic acid induced 14 |
| chr7_-_6523755 | 0.60 |
ENST00000436575.1
ENST00000258739.4 |
DAGLB
KDELR2
|
diacylglycerol lipase, beta KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
| chr7_-_19157248 | 0.59 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
| chr2_+_27665232 | 0.59 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
| chr12_-_58146128 | 0.59 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr14_-_24658053 | 0.59 |
ENST00000354464.6
|
IPO4
|
importin 4 |
| chr4_-_17783135 | 0.58 |
ENST00000265018.3
|
FAM184B
|
family with sequence similarity 184, member B |
| chr11_-_64889529 | 0.58 |
ENST00000531743.1
ENST00000527548.1 ENST00000526555.1 ENST00000279259.3 |
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed |
| chr19_+_18942720 | 0.58 |
ENST00000262803.5
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
| chr11_+_809961 | 0.58 |
ENST00000530797.1
|
RPLP2
|
ribosomal protein, large, P2 |
| chr11_-_63933504 | 0.58 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
| chr6_+_7108210 | 0.58 |
ENST00000467782.1
ENST00000334984.6 ENST00000349384.6 |
RREB1
|
ras responsive element binding protein 1 |
| chr13_-_103451307 | 0.57 |
ENST00000376004.4
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1 |
| chr9_+_112542572 | 0.57 |
ENST00000374530.3
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough |
| chr17_+_7476136 | 0.57 |
ENST00000582169.1
ENST00000578754.1 ENST00000578495.1 ENST00000293831.8 ENST00000380512.5 ENST00000585024.1 ENST00000583802.1 ENST00000577269.1 ENST00000584784.1 ENST00000582746.1 |
EIF4A1
|
eukaryotic translation initiation factor 4A1 |
| chr19_+_1407517 | 0.56 |
ENST00000336761.6
ENST00000233078.4 |
DAZAP1
|
DAZ associated protein 1 |
| chr10_-_101769617 | 0.56 |
ENST00000324109.4
ENST00000342239.3 |
DNMBP
|
dynamin binding protein |
| chr3_+_133292574 | 0.56 |
ENST00000264993.3
|
CDV3
|
CDV3 homolog (mouse) |
| chr8_-_101734907 | 0.56 |
ENST00000318607.5
ENST00000521865.1 ENST00000520804.1 ENST00000522720.1 ENST00000521067.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr1_-_159915386 | 0.56 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
| chr7_-_105925558 | 0.55 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr9_-_2844058 | 0.55 |
ENST00000397885.2
|
KIAA0020
|
KIAA0020 |
| chr3_+_32433154 | 0.55 |
ENST00000334983.5
ENST00000349718.4 |
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7 |
| chr11_+_125462690 | 0.55 |
ENST00000392708.4
ENST00000529196.1 ENST00000531491.1 |
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic) |
| chr17_-_34890709 | 0.55 |
ENST00000544606.1
|
MYO19
|
myosin XIX |
| chr11_+_809647 | 0.55 |
ENST00000321153.4
|
RPLP2
|
ribosomal protein, large, P2 |
| chr19_+_5720666 | 0.55 |
ENST00000381624.3
ENST00000381614.2 |
CATSPERD
|
catsper channel auxiliary subunit delta |
| chr17_-_27053216 | 0.54 |
ENST00000292090.3
|
TLCD1
|
TLC domain containing 1 |
| chr11_-_118927816 | 0.54 |
ENST00000534233.1
ENST00000532752.1 ENST00000525859.1 ENST00000404233.3 ENST00000532421.1 ENST00000543287.1 ENST00000527310.2 ENST00000529972.1 |
HYOU1
|
hypoxia up-regulated 1 |
| chr1_-_159894319 | 0.54 |
ENST00000320307.4
|
TAGLN2
|
transgelin 2 |
| chr12_-_58146048 | 0.53 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr9_+_112542591 | 0.53 |
ENST00000483909.1
ENST00000314527.4 ENST00000413420.1 ENST00000302798.7 ENST00000555236.1 ENST00000510514.5 |
PALM2
PALM2-AKAP2
AKAP2
|
paralemmin 2 PALM2-AKAP2 readthrough A kinase (PRKA) anchor protein 2 |
| chr6_-_43484718 | 0.53 |
ENST00000372422.2
|
YIPF3
|
Yip1 domain family, member 3 |
| chr19_+_18942761 | 0.53 |
ENST00000599848.1
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
| chr5_+_34656529 | 0.53 |
ENST00000513974.1
ENST00000512629.1 |
RAI14
|
retinoic acid induced 14 |
| chr8_+_104383759 | 0.53 |
ENST00000415886.2
|
CTHRC1
|
collagen triple helix repeat containing 1 |
| chr17_-_8534031 | 0.52 |
ENST00000411957.1
ENST00000396239.1 ENST00000379980.4 |
MYH10
|
myosin, heavy chain 10, non-muscle |
| chr10_-_30024716 | 0.52 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
Network of associatons between targets according to the STRING database.
First level regulatory network of ARNT
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 4.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.8 | 2.5 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.6 | 1.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.6 | 1.7 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.5 | 2.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.4 | 1.3 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.4 | 1.2 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.4 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.4 | 2.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.4 | 2.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.4 | 2.0 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.4 | 1.5 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.4 | 1.1 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.4 | 1.9 | GO:0015862 | uridine transport(GO:0015862) |
| 0.4 | 1.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 1.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 | 1.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.3 | 1.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.3 | 1.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 | 0.7 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 1.9 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 | 0.9 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.2 | 0.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 | 1.2 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.2 | 0.9 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.2 | 1.6 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.2 | 2.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 | 0.7 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 | 0.6 | GO:0035573 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 1.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.2 | 1.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.7 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 0.9 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.2 | 0.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 0.7 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.2 | 0.5 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 | 1.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 2.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.2 | 2.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 0.5 | GO:0002368 | B cell cytokine production(GO:0002368) protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 | 0.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 1.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.9 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 | 0.7 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.1 | 2.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 | 1.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 2.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 1.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 | 0.4 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 | 0.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.1 | 0.3 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.1 | 2.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 | 2.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.6 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 0.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.1 | 0.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 1.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 0.9 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.1 | 0.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 | 0.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.1 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 | 0.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 1.1 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.1 | 1.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.1 | 1.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.3 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 | 0.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 0.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 2.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 1.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 1.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.2 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.2 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.1 | 1.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.7 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 1.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.1 | 0.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 | 1.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 1.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 1.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 1.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.1 | 0.2 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
| 0.1 | 2.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.4 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.5 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.1 | 1.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.5 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 0.1 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.1 | 0.3 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.1 | 0.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.1 | 0.5 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.1 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 | 0.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 | 0.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.1 | 0.9 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.2 | GO:0021502 | neural fold elevation formation(GO:0021502) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.1 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.3 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.2 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 0.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.1 | 0.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.0 | 1.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 | 0.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 | 0.2 | GO:0045590 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 | 0.1 | GO:0060661 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.0 | 1.7 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 | 0.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 | 1.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.0 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 | 0.2 | GO:0048496 | adherens junction maintenance(GO:0034334) maintenance of organ identity(GO:0048496) |
| 0.0 | 0.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 | 0.2 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.0 | 0.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.0 | 0.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
| 0.0 | 0.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.0 | 0.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.0 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.0 | 1.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.0 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 | 0.1 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.0 | 1.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.6 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 | 0.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
| 0.0 | 1.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.0 | 0.2 | GO:1903748 | positive regulation of MHC class I biosynthetic process(GO:0045345) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.0 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.0 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 | 0.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 1.1 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 0.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.0 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 | 0.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.0 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.0 | 3.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.0 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 | 0.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 | 0.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.0 | 1.8 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.1 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.0 | 0.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 | 1.8 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.0 | 1.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.0 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.0 | 0.1 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.0 | 0.8 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.0 | 0.3 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.0 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 2.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.0 | 0.0 | GO:1902593 | single-organism nuclear import(GO:1902593) |
| 0.0 | 0.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 1.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
| 0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.0 | 0.0 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 | 0.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 1.4 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.1 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.0 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.0 | 0.3 | GO:0017145 | stem cell division(GO:0017145) |
| 0.0 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.0 | 0.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 | 0.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 0.0 | 1.3 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 | 0.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.0 | 0.3 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.0 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.5 | 1.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.4 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.2 | 1.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.2 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
| 0.1 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 1.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.6 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 1.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 2.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 1.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 1.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 2.3 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.3 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.2 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.0 | 2.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 1.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.0 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.0 | 1.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
| 0.0 | 0.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) Gemini of coiled bodies(GO:0097504) |
| 0.0 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
| 0.0 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.0 | 4.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 3.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.0 | 0.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.0 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.1 | GO:0031673 | H zone(GO:0031673) |
| 0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 1.9 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 0.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.0 | 1.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 1.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.8 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 1.5 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 0.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 5.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 1.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.0 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 1.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 2.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.8 | 2.4 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.7 | 2.0 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.5 | 2.5 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.5 | 1.4 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.4 | 1.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.4 | 1.2 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.4 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.3 | 2.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.3 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.3 | 1.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.3 | 1.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.3 | 1.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.3 | 1.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.3 | 2.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.2 | 1.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 0.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.2 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.2 | 0.7 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.2 | 0.7 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.2 | 0.9 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.2 | 1.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 1.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.2 | 0.5 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.2 | 1.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.2 | 0.5 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 0.6 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.2 | 0.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.9 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.1 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 0.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.1 | 2.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 1.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 0.6 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.1 | 0.5 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.1 | 0.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 0.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 0.3 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.1 | 0.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.1 | 0.2 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.1 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 1.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.1 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 0.4 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.1 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 0.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 0.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.3 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 2.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 1.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 1.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.0 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 0.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 1.0 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.0 | 1.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.0 | 1.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.0 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 1.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.0 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.0 | 2.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.0 | 2.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 1.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 2.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.0 | 0.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.0 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.0 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 2.2 | GO:0051287 | NAD binding(GO:0051287) |
| 0.0 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 1.7 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 5.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.1 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.0 | 0.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.0 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.0 | 2.5 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.0 | 1.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.1 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.0 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.0 | 0.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 2.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 3.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 1.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 4.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 2.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 4.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 5.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 2.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 2.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 5.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 3.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
| 0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 2.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 3.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 2.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 5.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 2.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 3.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 1.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 3.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 2.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 1.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 4.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.0 | 3.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 1.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.0 | 1.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 1.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.0 | 0.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 1.8 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 0.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 3.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.0 | 0.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |